This is a preview of subscription content, log in via an institution to check access.
Notes
ratio of differences in costs to differences in clinical effects of interventions relative to a standard comparator
ratio of incremental costs to incremental clinical effects of an intervention relative to its best alternative
Reference
O'Mahony JF, et al. HIQA's CEA of Breast Screening: Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not. Value in Health 18: 941-945, No. 8, Dec 2015. Available from: URL: http://doi.org/10.1016/j.jval.2015.08.009
Rights and permissions
About this article
Cite this article
HIQA's breast-screening analysis: ACERs not ICERs. PharmacoEcon Outcomes News 744, 18 (2016). https://doi.org/10.1007/s40274-016-2722-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2722-0